Athersys And To Collaborate On MultiStem Commercial Manufacturing In Japan

Athersys’ collaborator, HEALIOS K.K. (Healios), has an exclusive license to develop and market MultiStem in Japan for ischemic stroke … our ability to protect our intellectual property portfolio; our possible inability to execute our strategy due …
( read original story …)


Related Post

Japan lender SMFG eyeing M&A in asset manageme...
views 156
TOKYO Japanese lender Sumitomo Mitsui Financial Gr...
Japanese ambassador visits Manchester to discuss t...
views 184
The visit from Koji Tsuruoka aims to celebrate the...
Pliskova reaches Rogers Cup quarters after Osaka r...
views 127
TORONTO (Reuters) - Karolina Pliskova continued to...
Japan's top bank regulator warns of over-reli...
views 177
TOKYO May 9 Policymakers must seek ways to put the...
Nikkei jumps to highest in a year on Wall St stren...
views 106
TOKYO Dec 9 Japanese stocks rose to their highest ...
Ivanka Trump Was Closing Japanese Business Deal Wh...
views 136
The conflicts of interest for President-elect Dona...
Real Madrid advances to Club World Cup final
views 130
YOKOHAMA, Japan -- Real Madrid beat Mexican side C...
Nikkei: ADNOC To Decide On Japan Oil Concession Re...
views 125
TOKYO, July 28 (Reuters) - Abu Dhabi National Oil ...
Envirotainer Doubles e-Technology Capacity Across ...
views 131
As part of the investments in Japan and South Kore...
Saudi Aramco IPO Under Pressure, As 9/11 Lawsuits ...
views 214
Saudi Aramco’s IPO future looks a bit more bleak t...